Diet Management of Patients with Chronic Kidney Disease in Bariatric Surgery.
Marta PotrykusSylwia Czaja-StolcSylwia MałgorzewiczMonika Proczko-StepaniakAlicja Dębska-ŚlizieńPublished in: Nutrients (2022)
Morbid obesity is considered a civilization disease of the 21st century. Not only does obesity increase mortality, but it is also the most important cause of the shortening life expectancy in the modern world. Obesity is associated with many metabolic abnormalities: dyslipidemia, hyperglycemia, cardiovascular diseases, and others. An increasing number of patients diagnosed with chronic kidney disease (CKD) are obese. Numerous additional disorders associated with impaired kidney function make it difficult to conduct slimming therapy and may also be associated with a greater number of complications than in people with normal kidney function. Currently available treatments for obesity include lifestyle modification, pharmacotherapy, and bariatric surgery (BS). There are no precise recommendations on how to reduce excess body weight in patients with CKD treated conservatively, undergoing chronic dialysis, or after kidney transplantation. The aim of this study was to analyze studies on the bariatric treatment of obesity in this group of people, as well as to compare the recommendations typical for bariatrics and CKD.
Keyphrases
- weight loss
- bariatric surgery
- chronic kidney disease
- end stage renal disease
- metabolic syndrome
- roux en y gastric bypass
- obese patients
- gastric bypass
- insulin resistance
- weight gain
- type diabetes
- body weight
- high fat diet induced
- cardiovascular disease
- newly diagnosed
- ejection fraction
- stem cells
- cardiovascular events
- mesenchymal stem cells
- bone marrow
- cardiovascular risk factors
- smoking cessation
- drug induced
- replacement therapy